Valuation: Septerna, Inc.

Market Cap 174.81Cr 155.38Cr 144.02Cr 131.03Cr 247.27Cr 17TCr 251.23Cr 1.73TCr 678.75Cr 8.66TCr 656.04Cr 642.08Cr 28TCr P/E 2026 *
-27.7x
P/E 2027 * -16.4x
Enterprise Value 136.81Cr 121.61Cr 112.71Cr 102.55Cr 193.51Cr 13TCr 196.62Cr 1.35TCr 531.2Cr 6.78TCr 513.43Cr 502.5Cr 22TCr EV / Sales 2026 *
14.2x
EV / Sales 2027 * 17.3x
Free-Float
99.2%
Yield 2026 *
-
Yield 2027 * -
1 day-2.94%
1 week-1.49%
Current month-7.10%
1 month-6.46%
3 months+6.69%
6 months+40.19%
Current year+30.38%
1 week 34.36
Extreme 34.36
38.51
1 month 34.36
Extreme 34.36
41.09
Current year 22.78
Extreme 22.78
51.1
1 year 17.55
Extreme 17.55
51.1
3 years 4.17
Extreme 4.17
51.1
5 years 4.17
Extreme 4.17
51.1
10 years 4.17
Extreme 4.17
51.1
Manager TitleAgeSince
Chief Executive Officer 60 01/11/2021
Director of Finance/CFO 55 06/01/2025
President 58 01/08/2025
Director TitleAgeSince
Director/Board Member 60 01/11/2021
Chairman 50 01/11/2021
Director/Board Member 41 01/11/2021
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Free

Chief Technology Officer

2,75,000 0.5892%
01/09/26 Exercice

Executive/Senior Manager

9,999 0.0214%
12/08/26
RA Capital Management LP
SellCompany -14,93,000 3.3122%
Change 5-day change 1-year change 3-year change Capi.($)
-2.94%-1.49%+55.81% - 174.81Cr
-6.60%-10.93%+45.08%+60.01% 6.9TCr
-4.09%+3.12%+3.71%+53.50% 5.31TCr
+0.03%+7.21%+12.52%+44.46% 5.08TCr
-1.53%+3.10%+31.40%+33.88% 4.46TCr
-5.97%-5.40%+259.08%+494.98% 4.06TCr
-1.34%+5.41%+16.74%+106.42% 4.25TCr
+6.53%+8.02%+18.98%+54.58% 3.09TCr
-0.90%-10.91%+34.11%-1.83% 2.54TCr
-2.76%-4.73%-15.94%-15.32% 2.27TCr
Average -1.94%+1.52%+46.15%+92.30% 3.81TCr
Weighted average by Cap. -2.44%+1.65%+46.55%+96.53%

Financials

2026 *2027 *
Net sales 9.61Cr 8.55Cr 7.92Cr 7.21Cr 14Cr 912.4Cr 14Cr 95Cr 37Cr 476.13Cr 36Cr 35Cr 1.52TCr 7.36Cr 6.55Cr 6.07Cr 5.52Cr 10Cr 698.88Cr 11Cr 73Cr 29Cr 364.7Cr 28Cr 27Cr 1.16TCr
Net income -6.13Cr -5.45Cr -5.05Cr -4.59Cr -8.67Cr -581.75Cr -8.81Cr -61Cr -24Cr -303.58Cr -23Cr -23Cr -967.77Cr -12Cr -10Cr -9.48Cr -8.63Cr -16Cr -1.09TCr -17Cr -113.97Cr -45Cr -569.95Cr -43Cr -42Cr -1.82TCr
Net Debt -38Cr -34Cr -31Cr -28Cr -54Cr -3.61TCr -55Cr -376.33Cr -147.55Cr -1.88TCr -142.61Cr -139.58Cr -6TCr -48Cr -42Cr -39Cr -36Cr -67Cr -4.52TCr -68Cr -471.67Cr -184.93Cr -2.36TCr -178.75Cr -174.94Cr -7.52TCr
Projected Income Statement - Annual - Septerna, Inc.
Logo Septerna, Inc.
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. It is advancing programs in endocrinology, immunology and inflammation, metabolic diseases and additional therapeutic areas, both independently and with partners. The Company's Native Complex Platform is designed to enable it to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.
Employees
123
Date Price Change Volume
17/26/17 $36.35 -2.94% 2,34,122
15/26/15 $37.45 +3.11% 2,71,437
14/26/14 $36.32 -0.26% 3,69,978
13/26/13 $36.42 -3.05% 4,91,852
12/26/12 $37.56 -2.11% 2,07,564
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Septerna, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
37.45USD
Average target price
54.22USD
Spread / Average Target
+44.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Septerna, Inc.
  1. Stock Market
  2. Stocks
  3. SEPN Stock